SibylEWrayMD

PubMed

• Diroximel fumarate in patients with relapsing-remitting multiple sclerosis: Final safety and efficacy results from the phase 3 EVOLVE-MS-1 study.
  Barry A Singer, Douglas L Arnold, Jelena Drulovic, Mark S Freedman, Ralf Gold, Mark Gudesblatt, Elzbieta Jasinska, Christopher C LaGanke, Robert T Naismith, Donald Neg...> ;Multiple Sclerosis. 2023 Dec 1
• Matching-Adjusted Indirect Comparisons of Diroximel Fumarate, Ponesimod, and Teriflunomide for Relapsing Multiple Sclerosis.
  Tammy Jiang, Tjalf Ziemssen, Sibyl Wray, Changyu Shen, Karin Söderbärg, James B Lewin, Ivan Božin, Mark S Freedman> ;CNS Drugs. 2023 May 1
• 3 citations
  Satisfaction with alemtuzumab in relapsing multiple sclerosis patients: Results from the real-world PRO-ACT study.
  Sibyl Wray, Francois Jacques, Tamara A Miller, Jacqueline A Nicholas, Rafael Arroyo, Lori Travis, Bhupendra Khatri, Magdalena Chirieac, Roopali Gandhi, Nora Roesch, Am...> ;Multiple Sclerosis Journal - Experimental, Translational and Clinical. 2022 Nov 15
• 12 citations
  Efficacy and Safety Outcomes with Diroximel Fumarate After Switching from Prior Therapies or Continuing on DRF: Results from the Phase 3 EVOLVE-MS-1 Study.
  Sibyl Wray, Florian Then Bergh, Annette Wundes, Douglas L Arnold, Jelena Drulovic, Elzbieta Jasinska, James D Bowen, Donald Negroski, Robert T Naismith, Samuel F Hunte...> ;Advances in Therapy. 2022 Apr 1
• 2 citations
  Safety and clinical effectiveness of peginterferon beta-1a for relapsing multiple sclerosis in the real-world setting: interim results from the Plegridy Observational ...
  Marco Salvetti, Sibyl Wray, Gereon Nelles, Arman Altincatal, Achint Kumar, Thijs Koster, Plegridy Observational Program investigators> ;Multiple Sclerosis and Related Disorders. 2021 Oct 29
• 9 citations
  B cell depletion changes the immune cell profile in multiple sclerosis patients: One-year report.
  Amy E. Lovett-Racke, Yuhong Yang, Yue Liu, Matthew Gormley, Emma E. Kraus, Calsey Graham, Sibyl Wray, Michael K. Racke, Enrique Alvarez, Ann D Bass, Edward Fox> ;Journal of Neuroimmunology. 2021 Oct 15
• Patients' Experiences in Transitioning to Secondary Progressive Multiple Sclerosis: Qualitative Interviews.
  Sandy Lewis, Sibyl Wray, Emily Evans, Carla DeMuro Romano, Lauren Bartolome, Wendy Su, R. G. Shah, Patricia A. Russo> ;Neurology and Therapy. 2021 Aug 14
• 12 citations
  Improved gastrointestinal profile with diroximel fumarate is associated with a positive impact on quality of life compared with dimethyl fumarate: results from the ran...
  Annette Wundes, Sibyl Wray, Ralf Gold, Barry A Singer, Elzbieta Jasinska, Tjalf Ziemssen, Jérôme De Seze, Pavle Repovic, Hailu Chen, Jerome Hanna, Jordan Messer, Cathe...> ;Therapeutic Advances in Neurological Disorders. 2021 Mar 19
• 64 citations
  A phase 2 multicenter study of ublituximab, a novel glycoengineered anti-CD20 monoclonal antibody, in patients with relapsing forms of multiple sclerosis:
  Edward Fox, Amy E. Lovett-Racke, Matthew Gormley, Yue Liu, Maria Petracca, Sirio Cocozza, Richard Shubin, Sibyl Wray, Michael S Weiss, Jenna A. Bosco, Sean A. Power, K...> ;Multiple Sclerosis. 2021 Mar 1
• 14 citations
  Efficacy of alemtuzumab over 6 years in relapsing-remitting multiple sclerosis patients who relapsed between courses 1 and 2: Post hoc analysis of the CARE-MS studies.
  Bart Van Wijmeersch, Barry A Singer, Aaron Boster, Simon Broadley, Oscar Fernandez, Mark S. Freedman, Guillermo Izquierdo, Jan Lycke, Carlo Pozzilli, Basil Sharrack, B...> ;Multiple Sclerosis. 2020 Nov 1
• 56 citations
  Infection risk with alemtuzumab decreases over time: pooled analysis of 6-year data from the CAMMS223, CARE-MS I, and CARE-MS II studies and the CAMMS03409 extension s...
  Sibyl Wray, Eva Havrdova, David R. Snydman, Douglas L. Arnold, Jeffrey A. Cohen, Alasdair Coles, Hans-Peter Hartung, Krzysztof Selmaj, Howard L. Weiner, Nadia Daizadeh...> ;Multiple Sclerosis. 2019 Oct 1
• 33 citations
  B cell depletion with ublituximab reshapes the T cell profile in multiple sclerosis patients
  Amy E. Lovett-Racke, Matthew Gormley, Yue Liu, Yuhong Yang, Calsey Graham, Sibyl Wray, Michael K. Racke, Richard Shubin, Cary Twyman, Enrique Alvarez, Ann D Bass, Jame...> ;Journal of Neuroimmunology. 2019 Jul 15
• 5 citations
  Patients transitioning from non-pegylated to pegylated interferon beta-1a have a low risk of new flu-like symptoms: ALLOW phase 3b trial results.
  Robert T. Naismith, Barry Hendin, Sibyl Wray, Deren Huang, Fiorenza Gaudenzi, Qunming Dong, Bjorn Sperling, Monica Mann, Brian Werneburg> ;Multiple Sclerosis Journal - Experimental, Translational and Clinical. 2019 Jan 30
• 4 citations
  Treatment satisfaction significantly improves in patients with multiple sclerosis switching from interferon beta therapy to peginterferon beta-1a every 2 weeks.
  Barry Hendin, Robert T. Naismith, Sibyl Wray, Deren Huang, Qunming Dong, Terrie Livingston, Daniel L Jones, Crystal Watson, Mehul Jhaveri> ;Patient Preference and Adherence. 2018 Jul 20
• 3 citations
  Ease of use of two autoinjectors in patients with multiple sclerosis treated with interferon beta-1a subcutaneously three times weekly: results of the randomized, cros...
  Sibyl Wray, Brooke Hayward, Fernando Dangond, Barry A Singer> ;Expert Opinion on Drug Delivery. 2018 Feb 1
• 16 citations
  Subcutaneous peginterferon β-1a injection-site reaction experience and mitigation: Delphi analysis of the ALLOW study.
  Barry Hendin, De Ren Huang, Sibyl Wray, Robert T. Naismith, Sheri Rosenblatt, Javier Zambrano, Brian Werneburg> ;Neurodegenerative Disease Management. 2017 Jan 10
• 58 citations
  The state of multiple sclerosis: current insight into the patient/health care provider relationship, treatment challenges, and satisfaction.
  Mar Tintoré, Maggie Alexander, Kathleen Costello, Martin Duddy, David E. Jones, Nancy Law, Gilmore O'neill, Antonio Uccelli, Robert Weissert, Sibyl Wray> ;Patient Preference and Adherence. 2016 Dec 22
• 15 citations
  Results from the single-use autoinjector for self-administration of subcutaneous interferon beta-1a in patients with relapsing multiple sclerosis (MOSAIC) study
  Sibyl Wray, Robert Armstrong, Craig Herrman, Jonathan Calkwood, Mark Cascione, Watsky Eric Jacob, Brooke Hayward, Brian Mercer, Fernando Dangond> ;Expert Opinion on Drug Delivery. 2011 Nov 21
• 7 citations
  Neuron addition in the postmetamorphic frog.
  Paul B. Farel, Peter G. R. St. Wecker, Sibyl E. Wray> ;Experimental Gerontology. 1992 Jan 1
• Join now to see all